George Zahorian
Urology · Hershey, PANPI 1063636033
Payments from drug & device makers
Across 91 payments — averaging $24.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$553
- Smith+Nephew$380
- Organogenesis Inc.$235
- Sumitomo Pharma America, Inc.$196
- KCI USA, Inc.$116
- Kerecis Limited$100
- plus $606 from 15 others
What the payments were for
- Food & beverage$1,99191%
- Education$1718%
- Other$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 18 | $553 |
| Smith+Nephew | 20 | $380 |
| Organogenesis Inc. | 10 | $235 |
| Sumitomo Pharma America, Inc. | 10 | $196 |
| KCI USA, Inc. | 2 | $116 |
| Kerecis Limited | 2 | $100 |
| Tactile Systems Technology Inc | 5 | $94 |
| Convatec Inc. | 2 | $76 |
| Integra Lifesciences Corporation | 3 | $61 |
| Aroa Biosurgery Incorporated | 5 | $55 |
| Boston Scientific | 1 | $42 |
| Hartmann USA, Inc. | 1 | $42 |
| Myovant Sciences Inc. | 2 | $40 |
| Medline Industries LP | 2 | $40 |
| Urovant Sciences Inc | 2 | $39 |
| Olympus America Inc. | 1 | $25 |
| Solventum Corporation | 1 | $24 |
| AbbVie | 1 | $19 |
| Coloplast | 1 | $19 |
| Blue Earth Diagnostics | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$114
- KERRAFOAM GENTLE BORDER$100
How this compares
$2,187 in reported general payments places this provider in the 45th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 55 | $27,272 |
| SantylCollagenase Clostridium Hist. | 25 | $27,084 |
| Silodosin | 74 | $6,315 |
| Ketoconazole | 64 | $3,079 |
| Dutasteride | 67 | $1,943 |
| Hydroxychloroquine Sulfate | 25 | $1,237 |
| Doxycycline Hyclate | 57 | $869 |
| Hydrocortisone | 61 | $846 |
| Terconazole | 16 | $781 |
| Allopurinol | 55 | $670 |
| Bethanechol Chloride | 15 | $446 |
| CefuroximeCefuroxime Axetil | 25 | $395 |
| Torsemide | 17 | $372 |
| Fluconazole | 33 | $287 |
| Finasteride | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $553 | $27,27255 claims |
| Smith+NephewSantyl | $380 | $27,08425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 596 urology providers in Pennsylvania.
Other urology in Hershey
- Jay RamanHershey$226K
- John KnoedlerHershey$59K
- Susan MacdonaldHershey$51K
- Joe LittlejohnHershey$38K
- Laurence BelkoffBala Cynwyd$18.7M
- Paul SieberLancaster$12.6M
- Costas LallasPhiladelphia$3.6M
- John AndersonBethlehem$2.1M
- Jodi MaranchiePittsburgh$1.2M
- Kenneth LessansLancaster$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.